Results of treatment and criteria of progress of respiratory organs sarkoidosis

Authors

DOI:

https://doi.org/10.15587/2519-4798.2018.127681

Keywords:

sarcoidosis of respiratory organs, activity criteria, treatment, prognosis, interleukin-2

Abstract

The aim of the work. This research work is devoted to the development of new additional criteria for the activity of inflammatory process in sarcoidosis of respiratory organs. The goal is to assess the effectiveness of performed treatment of sarcoidosis of respiratory organs by using low-cost highly-sensitive inflammatory markers.

Materials and methods. The study involved 68 patients with lung sarcoidosis before and after the three-month treatment. In addition to general-clinical methods of examination, in patients with sarcoidosis we also determined the levels of TNF-α and IL-2.

Results. Patients with active lung sarcoidosis had 2.61 times (p<0.05) increased level of IL-2 in bronchoalveolar lavage fluid and 9.05 times (p<0.05) increased levels in peripheral blood serum; the levels of TNF-α increased by 4.98 times (p<0.05) in bronchoalveolar lavage fluid and by 3.2 times (p<0.05) in peripheral blood serum as compared to the findings in the control group of patients. The study showed that in the group of patients, where the efficacy of the prescribed therapy was noted, the level of IL-2 decreased by 2.08 times (p<0.05) in bronchoalveolar lavage fluid and by 3.76 times (p<0.05) in peripheral blood serum, and the concentration of TNF-α decreased by 3.87 times (p<0.05) in bronchoalveolar lavage fluid and by 2.06 times in peripheral blood serum as compared to the initial indices.

Conclusions. The decrease of TNF-α level in bronchoalveolar lavage fluid on the background of three-months treatment correlated (r=0.84; p<0.05) to the changes in peripheral blood serum; at the same time the decrease of TNF-α level in peripheral blood serum correlated (r=0.89; p<0.05) to the decrease of IL-2 in peripheral blood serum of patients with sarcoidosis of respiratory organs

Author Biographies

Kostiantyn Shvets, SHEE “Ivano-Frankivsk National Medical University” Galitska str., 2, Ivano-Frankivsk, Ukraine, 76000

Assistant

Department of Pulmonology and Phthisiology with a course of Occupational Diseases

Mykola Ostrovskyy, SHEE “Ivano-Frankivsk National Medical University” Galitska str., 2, Ivano-Frankivsk, Ukraine, 76000

MD, Professor, Head of Department

Department of Pulmonology and Phthisiology with a course of Occupational Diseases

References

  1. Feshchenko, Y. I., Protsyk, L. M., Cherednyk, Y. O. (2006). Sarkoidoz orhaniv dykhannia: suchasnyi stan problemy [Sarcoidosis of respirotary organs: present state of the problem]. Ukrainskyi pulmonolohichnyi zhurnal, 3, 5–10.
  2. Gavrysyuk, V. K. (2010). Sarkoidoz organov dihaniya [Pulmonary Sarcoidosis]. Zdorovia Ukrainy, 2, 29–31.
  3. Gribbin, J., Hubbard, R. B., Le Jeune, I., Smith, C. J. P., West, J., Tata, L. J. (2006). Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax, 61 (11), 980–985. doi: 10.1136/thx.2006.062836
  4. Karakatsani, A., Papakosta, D., Rapti, A., Antoniou, K. M., Dimadi, M., Markopoulou, A. et. al. (2009). Epidemiology of interstitial lung diseases in Greece. Respiratory Medicine, 103 (8), 1122–1129. doi: 10.1016/j.rmed.2009.03.001
  5. Ahmadzai, H., Loke, W. S. J., Huang, S., Herbert, C., Wakefield, D., Thomas, P. (2014). Biomarkers in sarcoidosis: a review. Current Biomarker Findings, 93. doi: 10.2147/cbf.s46196
  6. Hunninghake, G. W., Costabel, U., Ando, M., Baughman, R., Cordier, J. F., du Bois, R. et. al. (1999). ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis, 16 (2), 149–173.
  7. Havrysiuk, V. K., Merenkova, Ye. O., Humeniuk, H. L., Shadrina, O. V. (2014). Sarkoidoz organov dyhaniya: epidemiologiya, klinicheskie formy i stadiyi, rezul'taty lecheniya [Pulmonary sarcoidosis: epidemiology clinical forms and stages, results of treatment]. Zdorovia Ukrainy, 1 (25), 32–33.
  8. Baughman, R. P., Nunes, H., Sweiss, N. J., Lower, E. E. (2013). Established and experimental medical therapy of pulmonary sarcoidosis. European Respiratory Journal, 41 (6), 1424–1438. doi: 10.1183/09031936.00060612
  9. Mannino, D. M., Ford, E. S., & Redd, S. C. (2003). Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination. The American Journal of Medicine, 114 (9), 758–762. doi: 10.1016/s0002-9343(03)00185-2
  10. Sweiss, N. J., Curran, J., Baughman, R. P. (2007). Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts. Clinics in Dermatology, 25 (3), 341–346. doi: 10.1016/j.clindermatol.2007.03.012
  11. Meyer, K. C., Raghu, G. (2011). Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? European Respiratory Journal, 38 (4), 761–769. doi: 10.1183/09031936.00069509
  12. Takahashi, T., Azuma, A., Abe, S., Kawanami, O., Ohara, K., Kudoh, S. (2001). Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis. European Respiratory Journal, 18 (3), 515–521. doi: 10.1183/09031936.01.99104501
  13. Baughman, R. P., Culver, D. A., Judson, M. A. (2011). A Concise Review of Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 183 (5), 573–581. doi: 10.1164/rccm.201006-0865ci
  14. Pepys, M. B., Hirschfield, G. M. (2003). C-reactive protein: a critical update. Journal of Clinical Investigation, 111 (12), 1805–1812. doi: 10.1172/jci18921
  15. Costabel, U. (2001). Sarcoidosis: clinical update. European Respiratory Journal, 18, 56s–68s.
  16. Sahoo, D. H., Bandyopadhyay, D., Xu, M., Pearson, K., Parambil, J. G., Lazar, C. A. et. al. (2011). Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. European Respiratory Journal, 38 (5), 1145–1150. doi: 10.1183/09031936.00195010

Downloads

Published

2018-04-05

How to Cite

Shvets, K., & Ostrovskyy, M. (2018). Results of treatment and criteria of progress of respiratory organs sarkoidosis. ScienceRise: Medical Science, (3 (23), 33–38. https://doi.org/10.15587/2519-4798.2018.127681

Issue

No. 3 (23) (2018)

Section

Medical Science

License

Copyright (c) 2018 Kostiantyn Shvets, Mykola Ostrovskyy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.